Northern Trust’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.4M Buy
506,104
+76,333
+18% +$1.22M ﹤0.01% 2244
2025
Q4
$3.31M Sell
429,771
-36,715
-8% -$290K ﹤0.01% 2718
2025
Q3
$3.44M Buy
466,486
+63,337
+16% +$324K ﹤0.01% 2713
2025
Q2
$1.61M Buy
403,149
+293,853
+269% +$1.07M ﹤0.01% 3114
2025
Q1
$348K Buy
109,296
+3,283
+3% +$15.5K ﹤0.01% 3722
2024
Q4
$567K Buy
106,013
+563
+0.5% +$4.2K ﹤0.01% 3613
2024
Q3
$557K Buy
105,450
+22,460
+27% +$80.6K ﹤0.01% 3551
2024
Q2
$151K Buy
82,990
+18,041
+28% +$33.6K ﹤0.01% 3946
2024
Q1
$116K Sell
64,949
-68
-0.1% -$142 ﹤0.01% 4039
2023
Q4
$114K Hold
65,017
﹤0.01% 4081
2023
Q3
$94.9K Hold
65,017
﹤0.01% 4026
2023
Q2
$149K Buy
65,017
+3,349
+5% +$6.96K ﹤0.01% 3927
2023
Q1
$56.1K Hold
61,668
﹤0.01% 4237
2022
Q4
$52.4K Buy
61,668
+9,442
+18% +$8.36K ﹤0.01% 4275
2022
Q3
$43K Hold
52,226
﹤0.01% 4363
2022
Q2
$52K Hold
52,226
﹤0.01% 4399
2022
Q1
$86K Hold
52,226
﹤0.01% 4391
2021
Q4
$126K Sell
52,226
-7,036
-12% -$27.3K ﹤0.01% 4353
2021
Q3
$287K Hold
59,262
﹤0.01% 4009
2021
Q2
$158K Buy
59,262
+21,384
+56% +$58.9K ﹤0.01% 4235
2021
Q1
$116K Buy
37,878
+8,433
+29% +$30.5K ﹤0.01% 4253
2020
Q4
$105K Hold
29,445
﹤0.01% 4103
2020
Q3
$118K Buy
29,445
+2,535
+9% +$10.1K ﹤0.01% 3931
2020
Q2
$73K Hold
26,910
﹤0.01% 3981
2020
Q1
$57K Hold
26,910
﹤0.01% 3932
2019
Q4
$146K Sell
26,910
-336
-1% -$1.18K ﹤0.01% 3865
2019
Q3
$82K Sell
27,246
-114,471
-81% -$480K ﹤0.01% 3957
2019
Q2
$530K Sell
141,717
-9,071
-6% -$35.5K ﹤0.01% 3540
2019
Q1
$606K Sell
150,788
-554
-0.4% -$2.34K ﹤0.01% 3495
2018
Q4
$555K Sell
151,342
-200
-0.1% -$1.36K ﹤0.01% 3531
2018
Q3
$1.3M Buy
151,542
+1,696
+1% +$17K ﹤0.01% 3393
2018
Q2
$1.65M Buy
149,846
+61,276
+69% +$684K ﹤0.01% 3296
2018
Q1
$1.02M Buy
88,570
+944
+1% +$8.93K ﹤0.01% 3369
2017
Q4
$908K Sell
87,626
-1,823
-2% -$23.3K ﹤0.01% 3425
2017
Q3
$1.43M Buy
89,449
+2,924
+3% +$40.5K ﹤0.01% 3346
2017
Q2
$1.05M Buy
86,525
+42,739
+98% +$456K ﹤0.01% 3431
2017
Q1
$910K Buy
43,786
+5,792
+15% +$90.7K ﹤0.01% 3375
2016
Q4
$543K Buy
37,994
+3,027
+9% +$46K ﹤0.01% 3506
2016
Q3
$575K Buy
34,967
+3,440
+11% +$49.6K ﹤0.01% 3474
2016
Q2
$450K Buy
+31,527
New +$426K ﹤0.01% 3539

Other funds holding CRVS